Kenyan Doctors Warn Against US Ebola Quarantine Centre
Kenya Association of Physicians says establishing a US Ebola quarantine centre poses biosecurity risks due to the Bundibugyo strain's unknown vaccine.
June 1, 2026
1 min read
38 views
Source: standardmedia.co.ke
Image: standardmedia.co.ke
The Kenya Association of Physicians (KAP) has expressed concerns that establishing a US-funded Ebola quarantine centre in Kenya could pose a biosecurity threat. According to KAP, the Bundibugyo strain of Ebola, which is prevalent in the region, carries a significant risk as there is no known vaccine or treatment for it.
KAP stated that Kenya's diagnostic capabilities for the Bundibugyo strain are limited, and the proposed centre might not adequately address these challenges. The physicians urged the government to reconsider the plan, emphasizing the need for thorough risk assessment and public health safeguards.
The US government has not officially confirmed the details of the proposed centre, and no specific location in Kenya has been announced. The controversy highlights ongoing debates about balancing international health security cooperation with local biosecurity concerns.
❓ Frequently Asked Questions
What is the Bundibugyo strain of Ebola?
The Bundibugyo strain is a species of Ebola virus first identified in Uganda in 2007. It has a lower fatality rate than other strains but no approved vaccine or specific treatment.
Why are Kenyan doctors concerned about the US quarantine centre?
Kenyan doctors worry that the centre could introduce biosecurity risks, especially given the lack of vaccine and limited diagnostic capacity for the local Bundibugyo strain.
Has the US government confirmed plans for this centre?
As of June 1, 2026, the US government has not officially confirmed details of the proposed Ebola quarantine centre in Kenya.
